Skip to Main Content

Author Details

Kathryn G Roberts
St Jude Children's Research Hospital
2006
87
41
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37890117Outcomes in Children, Adolescents, and Young Adults With Down Syndrome and ALL: A Report From the Children's Oncology Group.J Clin Oncol2024
36658389Whole genome sequencing provides comprehensive genetic testing in childhood B-cell acute lymphoblastic leukaemia.Leukemia2023
37986997Biologic and clinical features of childhood gamma delta T-ALL: identification of STAG2/LMO2 γδ T-ALL as an extremely high risk leukemia in the very young.medRxiv2023
37729596Prognostic and Pharmacotypic Heterogeneity of Hyperdiploidy in Childhood ALL.J Clin Oncol2023
37216686The genomic landscape of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21.Blood2023
37196217Philadelphia-Like Genetic Rearrangements in Adults With B-Cell ALL: Refractoriness to Chemotherapy and Response to Tyrosine Kinase Inhibitor in <i>ABL</i> Class Rearrangements.JCO Precis Oncol2023
36877196Outcomes of adult patients with relapsed/refractory CRLF2 rearranged B-cell acute lymphoblastic leukemia.Am J Hematol2023
36604538Pharmacotypes across the genomic landscape of pediatric acute lymphoblastic leukemia and impact on treatment response.Nat Med2023
35192684Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemia.Blood2022
35442720Acute Leukemia Classification Using Transcriptional Profiles From Low-Cost Nanopore mRNA Sequencing.JCO Precis Oncol2022
35671062Amino acid stress response genes promote L-asparaginase resistance in pediatric acute lymphoblastic leukemia.Blood Adv2022
35590059Acute lymphoblastic leukemia displays a distinct highly methylated genome.Nat Cancer2022
36518527A convergent malignant phenotype in B-cell acute lymphoblastic leukemia involving the splicing factor SRRM1.NAR Cancer2022
36138187NUDT21 limits CD19 levels through alternative mRNA polyadenylation in B cell acute lymphoblastic leukemia.Nat Immunol2022
36050548The genomic landscape of pediatric acute lymphoblastic leukemia.Nat Genet2022
35247902ZNF384 Fusion Oncoproteins Drive Lineage Aberrancy in Acute Leukemia.Blood Cancer Discov2022
35115686Noncoding genetic variation in GATA3 increases acute lymphoblastic leukemia risk through local and global changes in chromatin conformation.Nat Genet2022
35084434Association of Genetic Ancestry With the Molecular Subtypes and Prognosis of Childhood Acute Lymphoblastic Leukemia.JAMA Oncol2022
35323882CDX2 and IDH1/2: new potential players in ALL.Blood2022
32881995Tumor-intrinsic and -extrinsic determinants of response to blinatumomab in adults with B-ALL.Blood2021
33626861The <i>EBF1-PDGFRB</i> T681I mutation is highly resistant to imatinib and dasatinib <i>in vitro</i> and detectable in clinical samples prior to treatment.Haematologica2021
33593877Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma.Cancer Discov2021
33707599Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia with kinase fusions in Taiwan.Sci Rep2021
33895809Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL.Blood2021
34907175Interleukin-7 receptor α mutational activation can initiate precursor B-cell acute lymphoblastic leukemia.Nat Commun2021
34424946The age of the bone marrow microenvironment influences B-cell acute lymphoblastic leukemia progression via CXCR5-CXCL13.Blood2021
34250504Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease-directed therapy.Blood Cancer Discov2021
34103329Enhancer Hijacking Drives Oncogenic <i>BCL11B</i> Expression in Lineage-Ambiguous Stem Cell Leukemia.Cancer Discov2021
34151288Network-based systems pharmacology reveals heterogeneity in LCK and BCL2 signaling and therapeutic sensitivity of T-cell acute lymphoblastic leukemia.Nat Cancer2021
34062932Genetic Alterations and Therapeutic Targeting of Philadelphia-Like Acute Lymphoblastic Leukemia.Genes (Basel)2021
34110416Degradation of Janus kinases in CRLF2-rearranged acute lymphoblastic leukemia.Blood2021
33288732The Heme-Regulated Inhibitor Pathway Modulates Susceptibility of Poor Prognosis B-Lineage Acute Leukemia to BH3-Mimetics.Mol Cancer Res2021
33197935SSBP2-CSF1R is a recurrent fusion in B-lineage acute lymphoblastic leukemia with diverse genetic presentation and variable outcome.Blood2021
33275800GATA3 rs3824662A allele in B-cell acute lymphoblastic leukemia in adults, adolescents and young adults: association with CRLF2 rearrangement and poor prognosis.Am J Hematol2021
33357483Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort study.Lancet Haematol2021
32220069At three years, patients with acute lymphoblastic leukaemia are still at risk for relapse. Results of the international MRC UKALLXII/ECOG E2993 trial.Br J Haematol2020
31653664The Biology of B-Progenitor Acute Lymphoblastic Leukemia.Cold Spring Harb Perspect Med2020
33164984Pharmacogenomics of intracellular methotrexate polyglutamates in patients' leukemia cells in vivo.J Clin Invest2020
32793890Mutational landscape and patterns of clonal evolution in relapsed pediatric acute lymphoblastic leukemia.Blood Cancer Discov2020
32589978Hyper-CVAD regimen in combination with ofatumumab as frontline therapy for adults with Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia: a single-arm, phase 2 trial.Lancet Haematol2020
32470390Extensive Remodeling of the Immune Microenvironment in B Cell Acute Lymphoblastic Leukemia.Cancer Cell2020
30643249PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia.Nat Genet2019
31015346OBI-3424, a Novel AKR1C3-Activated Prodrug, Exhibits Potent Efficacy against Preclinical Models of T-ALL.Clin Cancer Res2019
30510082Novel susceptibility variants at the <i>ERG</i> locus for childhood acute lymphoblastic leukemia in Hispanics.Blood2019
29487712Inhibition of mTORC1/C2 signaling improves anti-leukemia efficacy of JAK/STAT blockade in <i>CRLF2</i> rearranged and/or <i>JAK</i> driven Philadelphia chromosome-like acute B-cell lymphoblastic leukemia.Oncotarget2018
29997224Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the Children's Oncology Group.Blood2018
29880614ETV6-NTRK3 induces aggressive acute lymphoblastic leukemia highly sensitive to selective TRK inhibition.Blood2018
30504302Genetics and prognosis of ALL in children vs adults.Hematology Am Soc Hematol Educ Program2018
30466746Why and how to treat Ph-like ALL?Best Pract Res Clin Haematol2018
29773543TKI resistance in Ph-like ALL.Blood2018
  • 1 - 50 of 87

Recommended Authors

Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2016
Number of shared co-authors 7
The Ohio State University Comprehensive Cancer Center
Career Start Year 2011
Number of shared co-authors 8
Stanford University School of Medicine
Career Start Year 2008
Number of shared co-authors 10
Oregon Health & Science University
Career Start Year 2008
Number of shared co-authors 6
University of Colorado School of Medicine
Career Start Year 2008
Number of shared co-authors 0
Hospital Israelita Albert Einstein
Career Start Year 2007
Number of shared co-authors 6
CHU Sainte-Justine Research Center
Career Start Year 2007
Number of shared co-authors 2
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2006
Number of shared co-authors 8
Semmelweis University
Career Start Year 2006
Number of shared co-authors 0
Saint-Louis Hospital
Career Start Year 2005
Number of shared co-authors 6
Dana Farber Cancer Institute
Career Start Year 2005
Number of shared co-authors 9
Dana-Farber Cancer Institute
Career Start Year 2005
Number of shared co-authors 10
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Career Start Year 2004
Number of shared co-authors 19
Clinical Research Division, Fred Hutchinson Cancer Research Center
Career Start Year 2003
Number of shared co-authors 43
Emory University School of Medicine
Career Start Year 2003
Number of shared co-authors 8
Oregon Health & Science University School of Medicine
Career Start Year 2002
Number of shared co-authors 21
Universitatsklinikum Jena
Career Start Year 2002
Number of shared co-authors 5
Oregon Health and Science University
Career Start Year 2000
Number of shared co-authors 4
Washington University School of Medicine in St. Louis
Career Start Year 1998
Number of shared co-authors 16
German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)
Career Start Year 1996
Number of shared co-authors 7
University of Cambridge
Career Start Year 1996
Number of shared co-authors 10
University of Navarra
Career Start Year 1994
Number of shared co-authors 0
Oregon Health and Science University
Career Start Year 1993
Number of shared co-authors 8
Kyoto University
Career Start Year 1993
Number of shared co-authors 16
Hannover Medical School
Career Start Year 1993
Number of shared co-authors 20
Fred Hutchinson Cancer Center
Career Start Year 1992
Number of shared co-authors 12
Hematology and Clinical Immunology, Heinrich Heine University Dusseldorf
Career Start Year 1992
Number of shared co-authors 12
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 1991
Number of shared co-authors 8
Dana-Farber Cancer Institute
Career Start Year 1989
Number of shared co-authors 19
Fred Hutchinson Cancer Research Centre
Career Start Year 1987
Number of shared co-authors 50

Collaborators

St Jude Children's Research Hospital
Co-authored papers 77
Children's Hospital of Philadelphia
Co-authored papers 27
University of Washington
Co-authored papers 26
Changhai Hospital, Second Military Medical University
Co-authored papers 21
St. Jude Children's Research Hospital
Co-authored papers 21
Departments of Pharmaceutical Sciences.
Co-authored papers 18
St Jude Children's Research Hospital
Co-authored papers 18
Departments of Oncology. St. Jude Children's Research Hospital
Co-authored papers 16
Co-authored papers 16
St. Jude Children's Research Hospital
Co-authored papers 15
St. Jude Children's Research Hospital
Co-authored papers 14
Baylor College of Medicine
Co-authored papers 12
The University of Texas MD Anderson Cancer Center
Co-authored papers 11
St. Jude Children's Research Hospital.
Co-authored papers 10
St Jude Children's Research Hospital
Co-authored papers 10
The University of Texas MD Anderson Cancer Center
Co-authored papers 9
St Jude Children's Research Hospital
Co-authored papers 9
St. Jude Children's Research Hospital
Co-authored papers 8
Translational and Clinical Research Institute, Newcastle University
Co-authored papers 8
Mayo Clinic
Co-authored papers 8
Memorial Sloan-Kettering Cancer Center
Co-authored papers 7
St. Jude Children's Research Hospital
Co-authored papers 7
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 6
The Ohio State Comprehensive Cancer Center
Co-authored papers 6
National Cancer Institute
Co-authored papers 6
Colleges of Medicine, University of Florida
Co-authored papers 6
National Cancer Institute
Co-authored papers 5
St. Jude Children's Research Hospital
Co-authored papers 5
St. Jude Children's Research Hospital
Co-authored papers 5
University of Alabama at Birmingham
Co-authored papers 4